Trump Signs 9/11 Victims Fund Extension

President Donald Trump on Monday signed legislation that will extend the September 11th Victim Compensation Fund until 2092. During the signing ceremony at the White House, Trump was surrounding by first responders, survivors and family members of several who died in the 2001 terrorist attack on the United States. The U.S. House of Representatives and the U.S Senate voted overwhelmingly last week to approve the legislation that will provide a lifetime of assistance for victims and their families. The extension will allow the fund, first established in 2001, to pay for past and future medical claims of those effected by the attacks on the World Trade Center in New York City, the Pentagon in Washington D.C. and United Flight 93, which crashed in Shanksville, Pennsylvania. According to World Trade Center Registry, an estimated 410,000 people may have been exposed to asbestos and other hazardous debris of the attack on New York City. “Today is the day we come together as a nation to support our 9/11 heroes,” Trump said moments before the signing. “Our love and loyalty for the 9/11 responders knows no bounds. They answered terror with emotional strength of true American warriors.” Funding Benefits Mesothelioma Patients Close to 2,900 Americans were killed initially during the attack, and almost as many have died since, most of whom were part of the rescue and recovery efforts that were done under the toxic dust cloud that engulfed Manhattan for weeks afterw...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news

Related Links:

ConclusionsOur study demonstrates the antitumor effect of IL-24 on endometrial cancer and shows that IL-24 may be a promising therapeutic gene for endometrial cancer gene therapy.Graphical abstract
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
The U.S. Senate followed the House of Representatives on Tuesday and passed legislation that will extend the September 11 Victim Compensation Fund until 2092. The legislation will fund all current and future medical claims of those effected by the 9/11 terrorist attacks on the World Trade Center in New York City, the Pentagon in Washington, and United Flight 93, which crashed in Shanksville, Pennsylvania. The extension of funding will benefit victims who may develop mesothelioma linked to the more than 400 tons of asbestos that covered the 16-acre disaster zone after the twin towers fell. According to World Trade Center R...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
More News: American Health | Asbestosis | Asthma | Breast Cancer | Budgets | Cancer | Cancer & Oncology | Cardiovascular & Thoracic Surgery | Centers for Disease Control and Prevention (CDC) | Chronic Leukemia | Colon Cancer | Colorectal Cancer | Environmental Health | Esophagus Cancer | Funding | Gastroenterology | Head and Neck Cancer | Interstitial Lung Disease | Kidney Cancer | Leukemia | Lung Cancer | Lymphoma | Melanoma | Mesothelioma | Nonmelanoma Skin Cancer | Politics | Prostate Cancer | Respiratory Medicine | Skin | Skin Cancer | Statistics | Study | Thyroid | Thyroid Cancer | Toxicology | Trump | Urology & Nephrology | USA Health